Analyzing United American Healthcare (OTCMKTS:UAHC) & ClearPoint Neuro (NASDAQ:CLPT)

ClearPoint Neuro (NASDAQ:CLPT) and United American Healthcare (OTCMKTS:UAHC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Analyst Ratings

This is a summary of current ratings for ClearPoint Neuro and United American Healthcare, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	0	0	3	0	3.00
United American Healthcare	0	0	0	0	N/A

ClearPoint Neuro presently has a consensus price target of $12.00, indicating a potential upside of 117.79%. Given ClearPoint Neuro’s higher probable upside, equities analysts plainly believe ClearPoint Neuro is more favorable than United American Healthcare.

Risk and Volatility

ClearPoint Neuro has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Comparatively, United American Healthcare has a beta of -1.42, meaning that its share price is 242% less volatile than the S&P 500.

Earnings and Valuation

This table compares ClearPoint Neuro and United American Healthcare’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$23.96 million	6.23	-$22.09 million	($0.91)	-6.05
United American Healthcare	N/A	N/A	N/A	N/A	N/A

United American Healthcare has lower revenue, but higher earnings than ClearPoint Neuro.

Profitability

This table compares ClearPoint Neuro and United American Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-92.21%	-83.94%	-47.92%
United American Healthcare	N/A	N/A	N/A

Insider & Institutional Ownership

30.1% of ClearPoint Neuro shares are held by institutional investors. 6.1% of ClearPoint Neuro shares are held by insiders. Comparatively, 14.3% of United American Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

ClearPoint Neuro beats United American Healthcare on 5 of the 9 factors compared between the two stocks.

About ClearPoint Neuro

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

About United American Healthcare

United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.